Back to search
Publication

Clofazimine enteropathy in a pediatric bone marrow transplant recipient.

Abstract

Clofazimine, previously used in the treatment of leprosy, is now used for treatment of Mycobacterium avium complex infection in patients with acquired immune deficiency syndrome, dermatologic disorders, and graft-versus-host disease. An 11-year-old boy developed a severe enteropathy 2 years after initiation of clofazimine treatment for graft-versus-host disease. Clofazimine enteropathy caused by crystal deposition can be life-threatening.

More information

Type
Journal Article
Author
Parizhskaya M
Youssef N N
Di Lorenzo C
Goyal R K

More publications on: